SCHEMBL32686792

SCHEMBL32686792

N#Cc1cncc(C#N)c1CC1c2ccccc2C(=O)N1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL4I1 Q96RQ9 1/20 0.39
▸ HTR1A P08908 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ MAPK1 P28482 2/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ GRIN1 Q05586 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ DBF4 Q9UBU7 1/20 0.33
▸ OGT O15294 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667167 0.87 MAPK1 (0.39) IL4I1HTR1ADRD2MAPK1PDE10A
SCHEMBL31667275 0.87 IL4I1 (0.40) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31667230 0.86 HTR1A (0.40) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31666981 0.86 HTR1A (0.40) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31667691 0.86 HTR1A (0.40) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31667233 0.86 HTR1A (0.40) IL4I1HTR1ADRD2HPGDGRIN1
SCHEMBL31667011 0.86 HTR1A (0.40) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31667428 0.85 GRIN1 (0.41) IL4I1HTR1ADRD2HPGDGRIN1
SCHEMBL31667156 0.85 HTR1A (0.38) IL4I1HTR1ADRD2MAPK1HPGD
SCHEMBL31667190 0.85 HTR1A (0.38) IL4I1HTR1ADRD2MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 IL4I1 2872/4885HTR1A 1224/4885DRD2 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback